Trial Profile

A prospective multicenter cross-sectional study analyzing transcript expression of inflammatory markers in X-linked hypophosphatemia treated with standard of care SOC and burosumab therapy and in healthy controls

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Mar 2023 Results (n=40) comparing FGF23, Klotho, and FGF21 levels in teenagers with XLH compared to healthy controls (VITADOS cohort) after matching for age, gender, and puberty published in the Pediatric Nephrology
20 Sep 2022 New trial record
16 Sep 2022 Results published in the Journal of Clinical Endocrinology and Metabolism

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com